Pro Share Advisors LLC Ptc Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

  • $42.5 Billion
  • Q4 2024

A detailed history of Pro Share Advisors LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 25,102 shares of PTCT stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,102
Previous 18,938 32.55%
Holding current value
$1.3 Million
Previous $702,000 61.4%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$34.99 - $52.07 $215,678 - $320,959
6,164 Added 32.55%
25,102 $1.13 Million
Q3 2024

Nov 13, 2024
BUY
$30.39 - $37.66 $138,304 - $171,390
4,551 Added 31.63%
18,938 $702,000
Q2 2024

Aug 13, 2024
SELL
$24.69 - $40.12 $96,932 - $157,511
-3,926 Reduced 21.44%
14,387 $439,000
Q1 2024

May 08, 2024
BUY
$24.15 - $31.95 $37,770 - $49,969
1,564 Added 9.34%
18,313 $532,000
Q4 2023

Feb 14, 2024
BUY
$18.07 - $29.37 $47,271 - $76,831
2,616 Added 18.51%
16,749 $461,000
Q3 2023

Nov 13, 2023
BUY
$22.41 - $41.99 $2,666 - $4,996
119 Added 0.85%
14,133 $316,000
Q2 2023

Aug 10, 2023
BUY
$40.4 - $59.1 $25,411 - $37,173
629 Added 4.7%
14,014 $569,000
Q1 2023

May 11, 2023
SELL
$38.16 - $48.86 $61,017 - $78,127
-1,599 Reduced 10.67%
13,385 $648,000
Q4 2022

Feb 02, 2023
BUY
$33.53 - $54.79 $40,940 - $66,898
1,221 Added 8.87%
14,984 $571,000
Q3 2022

Nov 04, 2022
BUY
$41.85 - $53.85 $13,140 - $16,908
314 Added 2.33%
13,763 $691,000
Q2 2022

Aug 01, 2022
SELL
$25.6 - $45.23 $178,150 - $314,755
-6,959 Reduced 34.1%
13,449 $539,000
Q1 2022

May 10, 2022
SELL
$33.33 - $44.6 $157,350 - $210,556
-4,721 Reduced 18.79%
20,408 $762,000
Q4 2021

Feb 08, 2022
BUY
$35.36 - $41.86 $40,310 - $47,720
1,140 Added 4.75%
25,129 $1 Million
Q3 2021

Nov 12, 2021
SELL
$37.01 - $44.74 $247,559 - $299,265
-6,689 Reduced 21.8%
23,989 $893,000
Q2 2021

Aug 13, 2021
BUY
$37.95 - $49.37 $168,498 - $219,202
4,440 Added 16.92%
30,678 $1.3 Million
Q1 2021

May 14, 2021
BUY
$46.8 - $68.92 $94,536 - $139,218
2,020 Added 8.34%
26,238 $1.24 Million
Q4 2020

Feb 09, 2021
BUY
$47.96 - $67.64 $274,858 - $387,644
5,731 Added 31.0%
24,218 $1.48 Million
Q3 2020

Nov 13, 2020
BUY
$45.41 - $57.07 $1,861 - $2,339
41 Added 0.22%
18,487 $864,000
Q2 2020

Aug 03, 2020
BUY
$42.56 - $54.98 $272,937 - $352,586
6,413 Added 53.3%
18,446 $936,000
Q1 2020

May 15, 2020
SELL
$32.37 - $59.36 $306,997 - $562,970
-9,484 Reduced 44.08%
12,033 $537,000
Q4 2019

Feb 12, 2020
SELL
$32.22 - $50.07 $30,866 - $47,967
-958 Reduced 4.26%
21,517 $1.03 Million
Q3 2019

Nov 12, 2019
SELL
$33.82 - $48.17 $1,217 - $1,734
-36 Reduced 0.16%
22,475 $760,000
Q2 2019

Aug 13, 2019
SELL
$35.42 - $45.0 $90,533 - $115,020
-2,556 Reduced 10.2%
22,511 $1.01 Million
Q1 2019

May 15, 2019
BUY
$28.09 - $39.49 $90,253 - $126,881
3,213 Added 14.7%
25,067 $944,000
Q4 2018

Feb 14, 2019
SELL
$29.83 - $46.51 $124,689 - $194,411
-4,180 Reduced 16.06%
21,854 $750,000
Q3 2018

Nov 14, 2018
BUY
$33.9 - $47.77 $18,645 - $26,273
550 Added 2.16%
26,034 $1.22 Million
Q2 2018

Aug 13, 2018
BUY
$25.7 - $47.88 $30,248 - $56,354
1,177 Added 4.84%
25,484 $860,000
Q1 2018

May 14, 2018
SELL
$17.46 - $32.59 $69,822 - $130,327
-3,999 Reduced 14.13%
24,307 $658,000
Q4 2017

Feb 14, 2018
BUY
$15.14 - $20.89 $33,868 - $46,730
2,237 Added 8.58%
28,306 $472,000
Q3 2017

Nov 13, 2017
BUY
$16.81 - $21.61 $32,846 - $42,225
1,954 Added 8.1%
26,069 $522,000
Q2 2017

Aug 11, 2017
BUY
N/A
24,115
24,115 $442,000

Others Institutions Holding PTCT

# of Institutions
249
Shares Held
76.8M
Call Options Held
158K
Put Options Held
401K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.71B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email